Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Xiantong Pharmaceutical is a specialized pharmaceutical company focused on the development and manufacturing of radiopharmaceuticals. As a key subsidiary of Beijing Xiantong International Pharmaceutical, it operates a major production base in Sichuan to support the group's nuclear medicine portfolio. The company's primary focus areas include diagnostic and therapeutic agents for Alzheimer's disease and various oncology indications. It plays a critical role in the supply chain for advanced molecular imaging and targeted radionuclide therapy in the Chinese market. The company's facilities are designed to meet stringent GMP standards for the handling and distribution of radioactive isotopes. Sichuan Xiantong is a key player in expanding the accessibility of precision medicine and molecular imaging across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Xiantong Pharmaceutical.